Proliferative vitreoretinopathy as a late complication of blunt ocular trauma

Optometry

Volumn 79, Issue 4, 2008, Pages 197-202

  Waters, Tilena ^a   Vollmer, Lori ^a   Sowka, Joseph ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Ocular trauma; Perforating ocular injury; Proliferative vitreoretinopathy

Indexed keywords

ADULT; ARTICLE; BLUNT TRAUMA; CASE REPORT; EYE INJURY; HUMAN; MALE; PATHOLOGY; VISUAL DISORDER; VITRECTOMY; VITREORETINOPATHY;

ADULT; EYE INJURIES; HUMANS; MALE; VISION, LOW; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; WOUNDS, NONPENETRATING;

EID: 40749105609     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2007.09.016     Document Type: Article

References (23)

1. Cardillo J.A., Stout J.T., LaBree L., et al. Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology 104 7 (1997) 1166-1173
2. Mietz H., Kirchhof B., and Heimann K. Anterior proliferative vitreoretinopathy in trauma and complicated retinal detachment. A histopathologic study. Ger J Ophthalmol 3 1 (1994) 15-18
3. Weller M., Wiedemann P., and Heimann K. Proliferative vitreoretinopathy-Is it anything more than wound healing at the wrong place?. Int Ophthalmol 14 2 (1990) 105-117
4. Elner S., Elner V., MacKenzie Freeman H., et al. The pathology of anterior (peripheral) proliferative vitreoretinopathy. Tr Am Ophth Soc LXXXVI (1998) 330-353
5. Stödtler M., Holger M., Wiedemann P., et al. Immunohistochemistry of anterior proliferative vitreoretinopathy. Int Ophthalmol 18 (1995) 323-328
6. Charteris D., Downie J., Aylward W., et al. Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 245 1 (2007) 93-100
7. Pastor J.C., Rodríquez de la Rúa E., and Martín F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 21 (2002) 127-144
8. Pastor J.C. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol 43 1 (1998) 3-18
9. Bainbridge J.W.D., Mistry A.R., Thrasher A.J., et al. Gene therapy for ocular angiogenesis. Clin Sci 104 (2003) 561-575
10. Yeung L., Chen T., Kuo Y., et al. Severe vitreous hemorrhage associated with closed-globe injury. Graefes Arch Clin Exp Ophthalmol 244 (2006) 52-57
11. Abrams G.W., Azen S.P., McCuen II B.W., et al. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol 115 3 (1997) 335-344
12. Szurman P., Roters S., Grisanti S., et al. Primary silicone oil tamponade in the management of severe intraocular foreign body injuries: An 8-year follow-up. Retina 27 3 (2007) 304-311
13. Sebag J. Shaken not stirred. Guest editorial. Ophthalmology 108 (2001) 1177-1178
14. Algvere P.V., Hallnäs K., Dafgård E., et al. Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 228 (1990) 461-466
15. Ciulla T.A., Walker J.D., Fong D., et al. Corticosteroids in posterior segment disease: an update on new delivery systems and new indications. Curr Opin Ophthalmol 15 3 (2004) 211-220
16. Conti S.M., and Kertes P.J. The use of intravitreal corticosteroids, evidence-based and otherwise. Curr Opin Ophthalmol 17 3 (2006) 235-244
17. Yang C.S., Khawly J.A., Hainsworth D.P., et al. An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy. Arch Ophthalmol 116 (1998) 69-77
18. Asaria R.F.Y., Kon C.H., Bunce C., et al. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy. Ophthalmology 108 7 (2001) 1179-1183
19. Bi H.S., Cui Y., Zhang J.H., et al. Efficacy of 5-fluorouracil polyactic acid microsphere in prevention of proliferative vitreoretinopathy. Chinese Journal of Ophthalmology 42 1 (2006) 37-41
20. Scheer S., Morel C., Poisson F., et al. Prevention of proliferative vitreoretinopathy using 5-FU heparin: clinical tolerance and efficacy. Journal Francais d Opthalmologie 28 7 (2005) 701-706
21. Ozerdem U., Mach-Hofacre B., Keefe K., et al. The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathy. Ophthalm Res 33 (2001) 20-23
22. Mandava N., Blackburn P., Paul D., et al. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 43 10 (2002) 3338-3348
23. Asaria R.H.Y., Kon C.H., Bunce C., et al. How to predict proliferative vitreoretinopathy. Ophthalmology 108 (2001) 1184-1186